These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18404548)

  • 1. Investigation into the production of 2-Pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples.
    Syhre M; Scotter JM; Chambers ST
    Med Mycol; 2008 May; 46(3):209-15. PubMed ID: 18404548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel diagnostics: progress toward a breath test for invasive Aspergillus fumigatus.
    Chambers ST; Bhandari S; Scott-Thomas A; Syhre M
    Med Mycol; 2011 Apr; 49 Suppl 1():S54-61. PubMed ID: 20795766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of 2-pentylfuran in the breath of patients with Aspergillus fumigatus.
    Chambers ST; Syhre M; Murdoch DR; McCartin F; Epton MJ
    Med Mycol; 2009; 47(5):468-76. PubMed ID: 19301177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliotoxin production by clinical and environmental Aspergillus fumigatus strains.
    Kupfahl C; Michalka A; Lass-Flörl C; Fischer G; Haase G; Ruppert T; Geginat G; Hof H
    Int J Med Microbiol; 2008 Apr; 298(3-4):319-27. PubMed ID: 17574915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the limits and confounders for the 2-pentyl furan breath test by gas chromatography/mass spectrometry.
    Bhandari S; Chambers S; Pearson J; Syhre M; Epton M; Scott-Thomas A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(26):2815-20. PubMed ID: 21880557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments in novel breath tests for bacterial and fungal pulmonary infection.
    Chambers ST; Scott-Thomas A; Epton M
    Curr Opin Pulm Med; 2012 May; 18(3):228-32. PubMed ID: 22366996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
    Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
    Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex PCR for the discrimination of A. fumigatus, A. flavus, A. niger and A. terreus.
    Logotheti M; Kotsovili-Tseleni A; Arsenis G; Legakis NI
    J Microbiol Methods; 2009 Feb; 76(2):209-11. PubMed ID: 18992777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aspergillus spp. isolations from respiratory tract samples in Trakya University Hospital].
    Gürcan S; Demir M; Altiay G; Tikveşli M; Kiliç H; Otkun M
    Tuberk Toraks; 2007; 55(2):160-6. PubMed ID: 17602344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomedically important pathogenic fungi detection with volatile biomarkers.
    Bazemore RA; Feng J; Cseke L; Podila GK
    J Breath Res; 2012 Mar; 6(1):016002. PubMed ID: 22233561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A breath fungal secondary metabolite signature to diagnose invasive aspergillosis.
    Koo S; Thomas HR; Daniels SD; Lynch RC; Fortier SM; Shea MM; Rearden P; Comolli JC; Baden LR; Marty FM
    Clin Infect Dis; 2014 Dec; 59(12):1733-40. PubMed ID: 25342502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus.
    Pasqualotto AC
    Med Mycol; 2009; 47 Suppl 1():S261-70. PubMed ID: 18654921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
    Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
    J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of volatile organic compounds produced by clinical Aspergillus isolates using gas chromatography-mass spectrometry.
    Gerritsen MG; Brinkman P; Escobar N; Bos LD; de Heer K; Meijer M; Janssen HG; de Cock H; Wösten HAB; Visser CE; van Oers MHJ; Sterk PJ
    Med Mycol; 2018 Feb; 56(2):253-256. PubMed ID: 28525576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination.
    Tarrand JJ; Lichterfeld M; Warraich I; Luna M; Han XY; May GS; Kontoyiannis DP
    Am J Clin Pathol; 2003 Jun; 119(6):854-8. PubMed ID: 12817433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance.
    Krishnan S; Manavathu EK; Chandrasekar PH
    Mycoses; 2009 May; 52(3):206-22. PubMed ID: 19207851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antifungal susceptibilities of Aspergillus spp. strains isolated from invasive aspergillosis cases].
    Gürcan S; Tikveşli M; Eryildiz C; Evci C; Ener B
    Mikrobiyol Bul; 2010 Apr; 44(2):273-8. PubMed ID: 20549962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sniffing out the hypoxia volatile metabolic signature of Aspergillus fumigatus.
    Rees CA; Stefanuto PH; Beattie SR; Bultman KM; Cramer RA; Hill JE
    J Breath Res; 2017 Aug; 11(3):036003. PubMed ID: 28825403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics of Aspergillus fumigatus.
    Frisvad JC; Rank C; Nielsen KF; Larsen TO
    Med Mycol; 2009; 47 Suppl 1():S53-71. PubMed ID: 18763205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Cystic Fibrosis Aspergillus fumigatus Isolates Different? Intermicrobial Interactions with Pseudomonas.
    Nazik H; Moss RB; Karna V; Clemons KV; Banaei N; Cohen K; Choudhary V; Stevens DA
    Mycopathologia; 2017 Apr; 182(3-4):315-318. PubMed ID: 27822731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.